The retrieved documents are limited, so I will deliver a comprehensive answer from established clinical knowledge, supplemented by the retrieved reference.
Physiotherapy Assessment & Management of Muscular Dystrophy
Overview
Muscular dystrophies (MDs) are a heterogeneous group of inherited myopathies characterized by progressive skeletal muscle weakness and degeneration. The most clinically significant types include:
| Type | Inheritance | Onset | Key Features |
|---|
| Duchenne (DMD) | X-linked recessive | 2–5 yrs | Severe, rapidly progressive; Gowers' sign |
| Becker (BMD) | X-linked recessive | 5–15 yrs | Milder DMD variant |
| Limb-Girdle (LGMD) | AR / AD | Variable | Proximal limb-girdle weakness |
| Facioscapulohumeral (FSHD) | AD | Teens–30s | Face, shoulder girdle, foot dorsiflexors |
| Myotonic (DM1/DM2) | AD | Variable | Myotonia, distal weakness, multisystem |
| Emery-Dreifuss (EDMD) | X-linked/AD/AR | Childhood | Early contractures, cardiac conduction defects |
| Congenital (CMD) | AR | Birth–infancy | Hypotonia, structural CNS changes possible |
A multidisciplinary approach is essential across all types, with physiotherapy being a cornerstone at every disease stage (Bailey & Love's Short Practice of Surgery, 28th ed., p. 652).
Part 1: Physiotherapy Assessment
1.1 Initial History Taking
- Chief complaint: nature and onset of weakness, falls, difficulty rising from floor
- Functional history: loss of milestones (children), ADL limitations, stair climbing, wheelchair use
- Respiratory history: dyspnea, sleep disturbance, morning headaches, recurrent chest infections
- Family history: genetic pedigree
- Medical/surgical history: corticosteroid use, cardiac investigations, orthopaedic surgeries
- Medications: corticosteroids (deflazacort, prednisolone in DMD), heart medications
- Psychosocial history: school/work participation, caregiver burden, quality of life
1.2 Musculoskeletal Assessment
Muscle Strength Testing
| Tool | Details |
|---|
| Manual Muscle Testing (MMT) | MRC 0–5 scale; graded proximally and distally |
| Handheld Dynamometry (HHD) | Quantitative, reproducible; preferred for serial monitoring |
| Isokinetic Dynamometry | Research/specialized settings |
Key muscle groups to assess:
- Hip flexors, extensors, abductors
- Knee flexors and extensors
- Ankle dorsiflexors and plantarflexors
- Shoulder abductors, elbow flexors/extensors
- Neck flexors (often early weakness in myotonic dystrophy)
- Grip and pinch strength
Range of Motion (ROM) and Flexibility
- Goniometry for all major joints
- Prone hip extension, Thomas test, popliteal angle
- Ankle dorsiflexion ROM — critical predictor of ambulation loss
- Contractures: hip flexors, knee flexors, Achilles tendon (most common in DMD)
- Spine: thoracolumbar scoliosis screening — Cobb angle measurement referral if suspected
Posture and Alignment
- Lumbar hyperlordosis (compensatory in proximal weakness)
- Pelvic tilt, winging of scapulae (FSHD)
- Leg length discrepancy
- Foot deformities: equinovarus, pes planus
1.3 Functional Assessments
| Assessment Tool | Purpose |
|---|
| Timed Tests | |
| 10-Metre Walk Test (10MWT) | Gait speed, ambulation capacity |
| Timed Up and Go (TUG) | Mobility, dynamic balance |
| 6-Minute Walk Test (6MWT) | Submaximal exercise capacity, endurance |
| 10-Metre Run/Walk | DMD-specific; sensitive to change |
| Rising from Floor | Gowers' sign timing; functional floor transfer ability |
| Stair Climbing | 4-stair climb time (DMD natural history outcome) |
| Upper Limb Function | |
| Performance of Upper Limb (PUL) | Validated for DMD, non-ambulant stage |
| 9-Hole Peg Test | Fine motor and hand dexterity |
| Box & Block Test | Gross manual dexterity |
| Disease-Specific Scales | |
| North Star Ambulatory Assessment (NSAA) | 17-item validated scale for ambulant DMD |
| Hammersmith Functional Motor Scale (HFMS) | Non-ambulant neuromuscular conditions |
| Motor Function Measure (MFM-32) | Across all MD types, 3 domains |
| Vignos Scale | Functional ambulation staging in DMD |
| Brooke Scale | Upper limb functional staging |
1.4 Gait Analysis
- Observational gait analysis: Trendelenburg gait (hip abductor weakness), equinus, toe-walking, waddling/Duchenne gait
- Instrumented gait analysis (where available): kinematics, kinetics, EMG
- Energy expenditure during ambulation
- Assistive device assessment (crutches, rollator, KAFOs)
- Footwear and orthotic review
1.5 Respiratory Assessment
Respiratory involvement is a major cause of morbidity and mortality, especially in DMD, CMD, and Emery-Dreifuss MD.
| Assessment | Normal | Action Threshold |
|---|
| Spirometry (FVC) | >80% predicted | FVC <50%: refer to respiratory team |
| FVC supine vs. sitting | <10% difference | >10% drop suggests diaphragmatic weakness |
| Peak Cough Flow (PCF) | >360 L/min | <270 L/min: assisted cough needed; <160 L/min: ineffective cough |
| MIP (Max Inspiratory Pressure) | Variable | Low MIP: inspiratory muscle weakness |
| MEP (Max Expiratory Pressure) | Variable | Low MEP: impaired cough, secretion clearance |
| SpO₂ monitoring | ≥95% | Overnight oximetry for nocturnal hypoventilation |
| Nocturnal capnography | CO₂ <45 mmHg | Elevated: NIV indicated |
- Screen for symptoms of nocturnal hypoventilation: morning headaches, fatigue, poor sleep
- Assess secretion management: cough effectiveness, sputum volume
1.6 Spinal and Postural Assessment
- Scoliosis: common in DMD post-ambulation loss (~90% develop scoliosis after wheelchair use)
- Adam's forward bend test as screening tool
- Refer for radiological Cobb angle if suspected
- Kyphosis in FSHD, myotonic dystrophy
- Cervical and thoracic extensor weakness
1.7 Pain Assessment
- Often underreported in MD
- Musculoskeletal pain from overuse, poor posture, contractures
- Neuropathic pain (myotonic dystrophy)
- VAS / NRS / Brief Pain Inventory
1.8 Activity and Participation (ICF Framework)
Using the International Classification of Functioning, Disability and Health (ICF):
- Body function/structure: strength, ROM, respiratory function
- Activity: ADLs, mobility, self-care
- Participation: school, work, social interaction
- Environmental factors: home accessibility, equipment, support
- Personal factors: motivation, coping, self-efficacy
Tools: Paediatric Evaluation of Disability Inventory (PEDI), ACTIVLIM, SF-36, EQ-5D
Part 2: Physiotherapy Management
Management should be staged according to disease progression and tailored to the specific MD type.
2.1 Staging Framework
| Stage | Characteristics | PT Focus |
|---|
| Stage 1 (Early ambulant) | Mild weakness, independent ambulation | Stretching, strengthening, activity promotion |
| Stage 2 (Late ambulant) | Difficulty running, climbing stairs | Maintain ambulation, orthoses, respiratory monitoring |
| Stage 3 (Early non-ambulant) | Wheelchair dependent | UL function, seating, respiratory support |
| Stage 4 (Late non-ambulant) | Severe weakness, limited UL | Respiratory management, positioning, comfort |
2.2 Exercise Therapy
Strengthening Exercise
- Submaximal, low-resistance exercise is safe; eccentric overload and high-intensity exercise is contraindicated — dystrophic muscle is vulnerable to contraction-induced injury
- Recommended intensity: ≤60% of 1-RM, avoiding exhaustion
- Circuit training, aquatic therapy, functional strengthening are preferred
- Frequency: 3x/week; avoid exercise-induced fatigue
- Aquatic/Hydrotherapy: buoyancy reduces joint loading; warmth reduces spasticity; improves strength, ROM, and mood; recommended especially when land-based exercise is difficult
Aerobic/Cardiovascular Exercise
- Low-to-moderate intensity aerobic training improves cardiorespiratory fitness without accelerating muscle degeneration
- Cycling (active or passive), swimming, walking
- Target: 50–70% max heart rate
- Monitor for fatigue, myalgia, or dark urine (myoglobinuria) as signs of overexertion
Evidence Summary
| Exercise Type | Recommendation | Evidence |
|---|
| Submaximal aerobic exercise | Recommended | Moderate |
| Assisted cycling | Recommended | Moderate |
| Aquatic therapy | Recommended | Moderate |
| Maximal eccentric loading | Contraindicated | Strong |
| Prolonged immobility/bedrest | Avoid | Strong |
2.3 Contracture Prevention and Stretching
Contractures accelerate loss of ambulation and impair positioning.
Daily passive stretching program:
- Ankle plantarflexors (gastrocnemius-soleus): critical in DMD
- Hip flexors: prone lying ≥30 min/day
- Knee flexors (hamstrings)
- Wrist flexors (myotonic dystrophy)
- Elbow flexors, finger flexors (late stages)
Technique:
- Slow, sustained stretch, 20–30 seconds per repetition, 3–5 reps
- Never force to the point of pain
- Use prolonged positioning (standing frames, splints) as adjuncts
Prolonged Positioning:
- Night splints (AFOs): maintain ankle dorsiflexion, delay Achilles contracture
- Standing frames/tilt tables: weight-bearing to reduce lower limb contractures, maintain bone density, improve bowel function
- Prone lying: counteracts hip flexor and knee flexor contractures
2.4 Orthotic Management
| Orthosis | Purpose |
|---|
| Ankle-Foot Orthosis (AFO) | Foot drop correction, prevent equinus contracture, improve gait |
| Knee-Ankle-Foot Orthosis (KAFO) | Prolong ambulation in late ambulant stage |
| Spinal orthosis (TLSO) | Scoliosis management in non-ambulant (limited evidence for curve correction but may aid seating) |
| Wrist-hand orthosis | Maintain hand position, reduce contracture |
| Cervical collar | Neck extensor weakness (e.g., FSHD, myotonic dystrophy) |
2.5 Respiratory Physiotherapy
Respiratory physiotherapy is life-prolonging in MD, particularly DMD.
Secretion Clearance Techniques
| Technique | Indication |
|---|
| Manually Assisted Cough (MAC) | PCF 160–270 L/min |
| Mechanical Insufflation-Exsufflation (MI-E / CoughAssist) | PCF <160 L/min; acute illness |
| Active Cycle of Breathing Technique (ACBT) | Ambulant patients with adequate effort |
| Positive Expiratory Pressure (PEP) | Secretion mobilization |
| Postural drainage | As clinically indicated |
| High-frequency chest wall oscillation (HFCWO) | Where available |
Breath Stacking / Lung Volume Recruitment (LVR)
- Used to increase peak cough flow and prevent progressive atelectasis
- Manual Ambu bag stacking, glossopharyngeal breathing
- Indicated when MIC (Maximum Insufflation Capacity) > FVC
Ventilatory Support
- Non-invasive ventilation (NIV): first-line when FVC <50% predicted, symptomatic nocturnal hypoventilation, or SpO₂ <95%
- Physiotherapy role: education, mask fitting, tolerance training, troubleshooting
- Tracheostomy ventilation (invasive): considered when NIV becomes insufficient
2.6 Mobility and Assistive Technology
- Walking aids: progression from no aids → forearm crutches → rollator
- Power wheelchair: when ambulation ceases; tilt-in-space, headrest, pressure relief
- Manual wheelchair: for transport/caregiver-assisted mobility
- Adaptive seating: custom moulded seating for scoliosis/poor trunk control
- Environmental control systems: smart home technology for late-stage non-ambulant patients
- Hoists and transfer aids: ceiling track hoists, standing transfers
- Communication aids: where upper limb function is severely limited
2.7 Postural Management and Seating
- Critical in non-ambulant stage to manage scoliosis, pressure ulcer risk, and respiratory function
- Tilt-in-space wheelchair to redistribute pressure
- Lateral supports, thoracic supports for scoliosis
- Pressure mapping to optimize seating
- Regular repositioning schedule; education of caregivers
- Avoid prolonged sitting in kyphotic or asymmetric postures
2.8 Pain Management
- Postural correction and ergonomic advice
- TENS, heat/cold therapy
- Aquatic therapy for pain relief
- Education on activity pacing
- Referral to pain specialist if neuropathic component (especially myotonic dystrophy)
2.9 Fatigue Management
Fatigue is prevalent in MD and distinct from weakness.
- Activity pacing: energy conservation strategies, rest breaks
- Graded activity programs: avoiding boom-bust cycles
- Prioritization of activities
- Assistive devices to reduce energy expenditure
- Sleep hygiene; address nocturnal hypoventilation
2.10 Falls Prevention
- Balance training (proprioception, postural reactions) within safe limits
- Hip protectors
- Environmental modifications (remove trip hazards, grab rails)
- Education on safe falling technique and floor transfers
- Emergency call systems
2.11 Aquatic Physiotherapy
- Particularly beneficial when land-based exercise is limited
- Reduces joint stress, allows greater range of movement
- Improves respiratory function (hydrostatic pressure on chest wall)
- Psychological benefits
- Precautions: monitor fatigue closely; ensure pool exit strategy for non-ambulant patients; avoid if respiratory reserve is critically low
2.12 Palliative and End-Stage Care
- Comfort positioning and pressure care
- Respiratory symptom management (dyspnea, secretion burden)
- Communication support
- Caregiver education and support
- Liaison with palliative care team
- Quality of life focus over functional gains
Part 3: Disease-Specific Considerations
Duchenne Muscular Dystrophy (DMD)
- Most extensively researched; evidence base is strongest
- Corticosteroids (deflazacort/prednisolone): slow progression; physiotherapy must account for steroid-related effects (obesity, osteoporosis, vertebral fractures)
- Maintain ambulation as long as possible (walking prolongs lung and spine health)
- Transition to KAFO + spinal bracing when knees start to buckle
- Spinal surgery (posterior spinal fusion): when Cobb angle >20° and FVC >30%; physiotherapy is critical pre- and post-operatively
- Cardiac physiotherapy input (heart failure management, exercise prescription)
Becker MD
- Slower progression; many remain ambulant into adulthood
- Similar principles as DMD but less aggressive timeline
- Cardiac involvement (dilated cardiomyopathy) often precedes severe weakness — exercise prescription must account for cardiac status
Facioscapulohumeral (FSHD)
- Scapular stabilization exercises
- Scapular fixation surgery considered in severe cases
- Foot drop: AFO
- Pain management prominent (chronic pain is a major complaint)
- Asymmetric weakness; individual assessment critical
Limb-Girdle MD (LGMD)
- Wide heterogeneity between subtypes
- General principles apply: proximal strengthening, stretch, aquatic therapy
- Monitor respiratory and cardiac involvement by subtype
Myotonic Dystrophy (DM1/DM2)
- Distal weakness (differentiates from most MDs); grip weakness, foot drop
- Myotonia: grip myotonia, percussion myotonia — warm-up exercises, avoid cold
- Fatigue and hypersomnia: fatigue management strategies essential
- Dysphagia: speech and language therapy input, positioning for feeding
- Cognitive and behavioural features: adjust communication and education accordingly
- Respiratory involvement: often subclinical early; regular spirometry essential
Emery-Dreifuss MD
- Early contractures (elbow flexors, Achilles, cervical extensors) even before significant weakness — aggressive stretching from diagnosis
- Cardiac arrhythmias and conduction defects: exercise must be prescribed with cardiology guidance
Part 4: Goal-Setting and Outcome Monitoring
SMART Goals
Goals should be specific, measurable, achievable, relevant, time-bound, and aligned with the patient's own priorities.
Outcome Measures by Domain
| Domain | Measure |
|---|
| Strength | HHD, MMT |
| Ambulation | 6MWT, 10MWT, NSAA, MFM-32 |
| Upper limb | PUL, Brooke Scale |
| Respiratory | FVC%, PCF, MIP, MEP |
| QoL | PedsQL (children), SF-36, EQ-5D |
| Fatigue | Fatigue Severity Scale |
| Participation | ACTIVLIM, PEDI |
Monitoring Frequency (DMD example)
| Assessment | Frequency |
|---|
| Timed functional tests, NSAA | Every 6 months |
| ROM/contracture assessment | Every 6 months |
| Spirometry (FVC seated + supine) | Every 6 months |
| Scoliosis screening | Annually (or post-ambulation) |
| Cardiac review | Annually |
Part 5: Multidisciplinary Team (MDT) Collaboration
Physiotherapy works alongside (Bailey & Love's, p. 652):
| Team Member | Role |
|---|
| Neurologist/Paediatrician | Diagnosis, disease monitoring, drug therapies |
| Respiratory Physician | NIV initiation, sleep studies |
| Cardiologist | Cardiac monitoring, medication |
| Orthopaedic Surgeon | Tendon release, scoliosis surgery |
| Occupational Therapist | ADL adaptations, upper limb function, equipment |
| Speech & Language Therapist | Dysphagia, communication |
| Dietitian | Nutritional support (obesity with steroids, dysphagia) |
| Psychologist/Social Worker | Adjustment to disability, family support |
| Genetic Counsellor | Heritability, family planning |
| Physiotherapist | Comprehensive rehabilitation as above |
Summary
Physiotherapy in muscular dystrophy is proactive, not reactive. The key principles are:
- Regular structured assessment using validated, disease-specific tools
- Safe, submaximal exercise — avoid eccentric overload and exhaustion
- Daily stretching to delay contractures
- Respiratory physiotherapy started early, progressed to assisted cough and NIV as FVC declines
- Orthotic management to prolong ambulation and prevent deformity
- Functional mobility and assistive technology optimization at each stage
- MDT collaboration throughout the disease course
- Stage-appropriate goals — shifting from preservation of function to quality of life and comfort in advanced disease